Literature DB >> 16857394

Commentary: osteoarthritis of the knee and glucosamine.

R D Altman, S Abramson, O Bruyere, D Clegg, G Herrero-Beaumont, E Maheu, R Moskowitz, K Pavelka, J-Y Reginster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16857394     DOI： 10.1016/j.joca.2006.06.010

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN： 1063-4584            Impact factor:   6.576


× No keyword cloud information.
  13 in total

Review 1.  Type 2 diabetes mellitus and osteoarthritis.

Authors:  Nicola Veronese; Cyrus Cooper; Jean-Yves Reginster; Marc Hochberg; Jaime Branco; Olivier Bruyère; Roland Chapurlat; Nasser Al-Daghri; Elaine Dennison; Gabriel Herrero-Beaumont; Jean-François Kaux; Emmanuel Maheu; René Rizzoli; Roland Roth; Lucio C Rovati; Daniel Uebelhart; Mila Vlaskovska; André Scheen
Journal:  Semin Arthritis Rheum       Date:  2019-01-11       Impact factor: 5.532

2.  Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial.

Authors:  C Kent Kwoh; Frank W Roemer; Michael J Hannon; Carolyn E Moore; John M Jakicic; Ali Guermazi; Stephanie M Green; Rhobert W Evans; Robert Boudreau
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

3.  Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: in vitro and in vivo investigations.

Authors:  Tobias D Henning; Rakhee Gawande; Aman Khurana; Sidhartha Tavri; Lydia Mandrussow; Daniel Golovko; Andrew Horvai; Barbara Sennino; Donald McDonald; Reinhard Meier; Michael Wendland; Nikita Derugin; Thomas M Link; Heike E Daldrup-Link
Journal:  Mol Imaging       Date:  2012-06       Impact factor: 4.488

Review 4.  Nutraceuticals in the management of osteoarthritis : a critical review.

Authors:  Ryan L Ragle; Allen D Sawitzke
Journal:  Drugs Aging       Date:  2012-09       Impact factor: 3.923

5.  Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study.

Authors:  Jessie A Satia; Alyson Littman; Christopher G Slatore; Joseph A Galanko; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

Review 6.  Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis.

Authors:  Olivier Bruyere; Jean-Yves Reginster
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 7.  Role of glucosamine in the treatment for osteoarthritis.

Authors:  Jean-Yves Reginster; Audrey Neuprez; Marie-Paule Lecart; Nathalie Sarlet; Olivier Bruyere
Journal:  Rheumatol Int       Date:  2012-03-30       Impact factor: 2.631

8.  The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model.

Authors:  Jana Riegger; Julia Baumert; Frank Zaucke; Rolf E Brenner
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

9.  The horse as a model of naturally occurring osteoarthritis.

Authors:  C W McIlwraith; D D Frisbie; C E Kawcak
Journal:  Bone Joint Res       Date:  2012-11-01       Impact factor: 5.853

10.  Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities.

Authors:  Yves Henrotin; Xavier Chevalier; Gabriel Herrero-Beaumont; Timothy McAlindon; Ali Mobasheri; Karel Pavelka; Christiane Schön; Harrie Weinans; Hans Biesalski
Journal:  BMC Res Notes       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.